Pascal Schneider

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


257 publications

... | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1990 |
2000
BAFF mediates survival of peripheral immature B lymphocytes.
Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F., 2000. Journal of Experimental Medicine, 192 (10) pp. 1453-1466.
[URN][DOI][WoS][Pmid][serval:BIB_48F8BF4595A9]
Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL.
Bodmer J.L., Meier P., Tschopp J., Schneider P., 2000. Journal of Biological Chemistry, 275 (27) pp. 20632-20637.
[URN][DOI][WoS][Pmid][serval:BIB_15C09F6E6B8D]
Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.
Holler N., Kataoka T., Bodmer J.L., Romero P., Romero J., Deperthes D., Engel J., Tschopp J., Schneider P., 2000. Journal of Immunological Methods, 237 (1-2) pp. 159-173.
[URN][DOI][WoS][Pmid][serval:BIB_69A67AAF39A6]
Edar/Eda interactions regulate enamel knot formation in tooth morphogenesis.
Tucker A.S., Headon D.J., Schneider P., Ferguson B.M., Overbeek P., Tschopp J., Sharpe P.T., 2000. Development, 127 (21) pp. 4691-4700.
[URN][WoS][Pmid][serval:BIB_AD530B19B2D2]
 
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., Tschopp J., 2000. Nature Immunology, 1 (6) pp. 489-495.
[DOI][WoS][Pmid][serval:BIB_618631F35AED]
FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation.
Rochat-Steiner V., Becker K., Micheau O., Schneider P., Burns K., Tschopp J., 2000. Journal of Experimental Medicine, 192 (8) pp. 1165-1174.
[URN][DOI][WoS][Pmid][serval:BIB_629A98B92559]
 
Modulation of death receptor signalling.
Schneider P., Tschopp J., 2000. Symposia of the Society for Experimental Biology, 52 pp. 31-42.
[Pmid][serval:BIB_94F0C24A8F13]
 
Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins.
Schneider P., 2000. Methods in Enzymology, 322 pp. 325-345.
[WoS][Pmid][serval:BIB_300EDEC80360]
The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
Mühlenbeck F., Schneider P., Bodmer J.L., Schwenzer R., Hauser A., Schubert G., Scheurich P., Moosmayer D., Tschopp J., Wajant H., 2000. Journal of Biological Chemistry, 275 (41) pp. 32208-32213.
[URN][DOI][WoS][Pmid][serval:BIB_3ED2A05AC91F]
 
TRAIL receptor-2 signals apoptosis through FADD and caspase-8.
Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., Tschopp J., 2000. Nature Cell Biology, 2 (4) pp. 241-243.
[DOI][WoS][Pmid][serval:BIB_90BF63CA741E]
1999
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.
Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H. et al., 1999. Journal of Experimental Medicine, 189 (11) pp. 1747-1756.
[URN][DOI][WoS][Pmid][serval:BIB_53CE7E893D3E]
 
Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.
Benedict C.A., Butrovich K.D., Lurain N.S., Corbeil J., Rooney I., Schneider P., Tschopp J., Ware C.F., 1999. Journal of Immunology, 162 (12) pp. 6967-6970.
[WoS][Pmid][serval:BIB_942D078842B4]
Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase.
Thome M., Martinon F., Hofmann K., Rubio V., Steiner V., Schneider P., Mattmann C., Tschopp J., 1999. Journal of Biological Chemistry, 274 (15) pp. 9962-9968.
[URN][DOI][WoS][Pmid][serval:BIB_4257D9EF40E8]
MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (gp63).
Corradin S., Ransijn A., Corradin G., Roggero M.A., Schmitz A.A., Schneider P., Mauël J., Vergères G., 1999. Journal of Biological Chemistry, 274 (36) pp. 25411-25418.
[URN][DOI][WoS][Pmid][serval:BIB_09CCF8818B94]
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L., 1999. Journal of Experimental Medicine, 190 (11) pp. 1697-1710.
[URN][DOI][WoS][Pmid][serval:BIB_DBCE91255287]
TWEAK can induce cell death via endogenous TNF and TNF receptor 1.
Schneider P., Schwenzer R., Haas E., Mühlenbeck F., Schubert G., Scheurich P., Tschopp J., Wajant H., 1999. European Journal of Immunology, 29 (6) pp. 1785-1792.
[URN][DOI][WoS][Pmid][serval:BIB_C46EED5E330C]
1998
 
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells.
Eberl G., Jiang S., Yu Z., Schneider P., Corradin G., Mach J.P., 1998. Clinical and Experimental Immunology, 114 (2) pp. 173-178. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_703F4655F900]
 
Analysis of the carbohydrate and lipid components of glycosylphosphatidylinositol structures.
Treumann A., Güther M.L., Schneider P., Ferguson M.A., 1998. Methods in Molecular Biology, 76 pp. 213-235.
[DOI][Pmid][serval:BIB_362B4720BC4C]
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.
Hahne M., Kataoka T., Schröter M., Hofmann K., Irmler M., Bodmer J.L., Schneider P., Bornand T., Holler N., French L.E. et al., 1998. Journal of Experimental Medicine, 188 (6) pp. 1185-1190.
[URN][DOI][WoS][Pmid][serval:BIB_4D2F3D6E5271]
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J., 1998. Journal of Experimental Medicine, 187 (8) pp. 1205-1213.
[URN][DOI][WoS][Pmid][serval:BIB_1966F35B4E9F]
 
FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation.
Kataoka T., Schröter M., Hahne M., Schneider P., Irmler M., Thome M., Froelich C.J., Tschopp J., 1998. Journal of Immunology, 161 (8) pp. 3936-3942.
[WoS][Pmid][serval:BIB_8F08756AB04B]
 
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.
Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., Hunziker T., Saurat J.H., Tschopp J., French L.E., 1998. Science, 282 (5388) pp. 490-493.
[DOI][WoS][Pmid][serval:BIB_4E0C4E1AA94B]
MyD88, an adapter protein involved in interleukin-1 signaling.
Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., Tschopp J., 1998. Journal of Biological Chemistry, 273 (20) pp. 12203-12209.
[URN][DOI][WoS][Pmid][serval:BIB_5FF43594B66A]
1997
Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.
Schneider P., Bodmer J.L., Holler N., Mattmann C., Scuderi P., Terskikh A., Peitsch M.C., Tschopp J., 1997. Journal of Biological Chemistry, 272 (30) pp. 18827-18833.
[URN][DOI][WoS][Pmid][serval:BIB_FAE0CCA4B4B0]
Characterization of two receptors for TRAIL.
Schneider P., Bodmer J.L., Thome M., Hofmann K., Holler N., Tschopp J., 1997. FEBS letters, 416 (3) pp. 329-34. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_25D695CC2FFE]
Inhibition of death receptor signals by cellular FLIP.
Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schröter M., Burns K., Mattmann C. et al., 1997. Nature, 388 (6638) pp. 190-195.
[URN][DOI][WoS][Pmid][serval:BIB_B780D8F4383C]
 
Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway.
Becker K., Schneider P., Hofmann K., Mattmann C., Tschopp J., 1997. FEBS Letters, 412 (1) pp. 102-106.
[DOI][WoS][Pmid][serval:BIB_5A0A58FED20C]
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.
Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., Tschopp J., 1997. Immunity, 7 (6) pp. 831-836.
[URN][DOI][WoS][Pmid][serval:BIB_1D571B98E298]
 
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).
Bodmer J.L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schröter M., Becker K. et al., 1997. Immunity, 6 (1) pp. 79-88.
[DOI][WoS][Pmid][serval:BIB_9C9827A6B3DC]
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.
Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schröter M. et al., 1997. Nature, 386 (6624) pp. 517-521.
[URN][DOI][WoS][Pmid][serval:BIB_0C9041508C29]
1996
 
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
Hahne M., Rimoldi D., Schröter M., Romero P., Schreier M., French L.E., Schneider P., Bornand T., Fontana A., Lienard D. et al., 1996. Science, 274 (5291) pp. 1363-1366.
[DOI][WoS][Pmid][serval:BIB_7B7255CAE951]
1995
 
Biosynthesis of the glycolipid anchor of lipophosphoglycan and the structurally related glycoinositolphospholipids from Leishmania major.
Proudfoot L., Schneider P., Ferguson M.A., McConville M.J., 1995. Biochemical Journal, 308 ( Pt 1) (1) pp. 45-55.
[WoS][Pmid][serval:BIB_73CA0DEC00C8]
Detection of serum antibodies against Leishmania 94 kDa antigen in visceral and cutaneous leishmaniosis due to Leishmania infantum.
Rolland L., Belkaid M., Seye A., Schneider P., Gentilini M., 1995. Parasite, 2 (1) pp. 13-21.
[URN][WoS][Pmid][serval:BIB_C178D9171832]
 
Leishmanolysin: surface metalloproteinase of Leishmania.
Bouvier J., Schneider P., Etges R., 1995. Methods in Enzymology, 248 pp. 614-633.
[WoS][Pmid][serval:BIB_A0A71796660E]
 
Microscale analysis of glycosylphosphatidylinositol structures.
Schneider P., Ferguson M.A., 1995. Methods in Enzymology, 250 pp. 614-630.
[WoS][Pmid][serval:BIB_9CFEF5509074]
Primary structure of CD52.
Treumann A., Lifely M.R., Schneider P., Ferguson M.A., 1995. Journal of Biological Chemistry, 270 (11) pp. 6088-6099.
[WoS][Pmid][serval:BIB_5980B24CF5C2]
 
Role of glutathione in macrophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity.
Buchmüller-Rouiller Y., Corrandin S.B., Smith J., Schneider P., Ransijn A., Jongeneel C.V., Mauël J., 1995. Cellular Immunology, 164 (1) pp. 73-80.
[DOI][WoS][Pmid][serval:BIB_2627A5DF2223]
Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan.
Sacks D.L., Pimenta P.F., McConville M.J., Schneider P., Turco S.J., 1995. Journal of Experimental Medicine, 181 (2) pp. 685-697.
[DOI][WoS][Pmid][serval:BIB_7DF288AFA738]
 
Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species.
McConville M.J., Schnur L.F., Jaffe C., Schneider P., 1995. Biochemical Journal, 310 ( Pt 3) (3) pp. 807-818.
[WoS][Pmid][serval:BIB_94DAE932F577]
 
The biosynthesis of GDP-D-arabinopyranose in Crithidia fasciculata: characterization of a D-arabino-1-kinase activity and its use in the synthesis of GDP-[5-3H]D-arabinopyranose.
Schneider P., Nikolaev A., Ferguson M.A., 1995. Biochemical Journal, 311 (1) pp. 307-315.
[WoS][Pmid][serval:BIB_37737CAF9053]
 
The glycoinositol-phospholipids of Phytomonas.
Redman C.A., Schneider P., Mehlert A., Ferguson M.A., 1995. Biochemical Journal, 311 (2) pp. 495-503.
[WoS][Pmid][serval:BIB_31476BAE97AC]
1994
Characterization of GDP-alpha-D-arabinopyranose, the precursor of D-Arap in Leishmania major lipophosphoglycan.
Schneider P., McConville M.J., Ferguson M.A., 1994. Journal of Biological Chemistry, 269 (28) pp. 18332-18337.
[WoS][Pmid][serval:BIB_303EE2D25069]
 
Glycoinositol-phospholipid profiles of four serotypically distinct Old World Leishmania strains.
Schneider P., Schnur L.F., Jaffe C.L., Ferguson M.A., McConville M.J., 1994. Biochemical Journal, 304 ( Pt 2) (2) pp. 603-609.
[WoS][Pmid][serval:BIB_0ACB6CB55FAB]
 
The developmental regulation and biosynthesis of GPI-related structures in Leishmania parasites.
McConville M.J., Schneider P., Proudfoot L., Masterson C., Ferguson M.A., 1994. Brazilian Journal of Medical and Biological Research, 27 (2) pp. 139-144.
[WoS][Pmid][serval:BIB_F8B5D0903971]
1993
 
A fluorescent peptide substrate for the surface metalloprotease of Leishmania.
Bouvier J., Schneider P., Malcolm B., 1993. Experimental Parasitology, 76 (2) pp. 146-155.
[DOI][WoS][Pmid][serval:BIB_B8E3E6E367ED]
 
Analysis of the neutral glycan fractions of glycosyl-phosphatidylinositols by thin-layer chromatography.
Schneider P., Ralton J.E., McConville M.J., Ferguson M.A., 1993. Analytical Biochemistry, 210 (1) pp. 106-112.
[DOI][WoS][Pmid][serval:BIB_7218894DA657]
 
Characterisation of two soluble metalloexopeptidases in the protozoan parasite Leishmania major.
Schneider P., Glaser T.A., 1993. Molecular and Biochemical Parasitology, 62 (2) pp. 223-231.
[DOI][WoS][Pmid][serval:BIB_8A0081AB1957]
 
Characterization of a surface metalloprotease from Herpetomonas samuelpessoai and comparison with Leishmania major promastigote surface protease.
Schneider P., Glaser T.A., 1993. Molecular and Biochemical Parasitology, 58 (2) pp. 277-282.
[DOI][WoS][Pmid][serval:BIB_8650ECC5B2A6]
 
Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major.
Schneider P., Rosat J.P., Ransijn A., Ferguson M.A., McConville M.J., 1993. Biochemical Journal, 295 (2) pp. 555-564.
[WoS][Pmid][serval:BIB_23D2862676C9]
 
Conservation of surface molecules in the trypanosomatids.
McConville M.J., Schneider P., 1993. Parasitology Today, 9 (9) pp. 316-317.
[DOI][WoS][Pmid][serval:BIB_29EA7CBD46FC]
 
Membrane insertion and antibody recognition of a glycosylphosphatidylinositol-anchored protein: an optical study.
Ramsden J.J., Schneider P., 1993. Biochemistry, 32 (2) pp. 523-529.
[DOI][WoS][Pmid][serval:BIB_EFC76C5E887D]
The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis.
McConville M.J., Collidge T.A., Ferguson M.A., Schneider P., 1993. Journal of Biological Chemistry, 268 (21) pp. 15595-15604.
[WoS][Pmid][serval:BIB_FB9614F0B761]
1992
 
3-amino-1,2,4-triazole inhibits macrophage NO synthase.
Buchmüller-Rouiller Y., Schneider P., Betz-Corradin S., Smith J., Mauël J., 1992. Biochemical and Biophysical Research Communications, 183 (1) pp. 150-155.
[DOI][WoS][Pmid][serval:BIB_552E6685057C]
 
Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages.
Schneider P., Rosat J.P., Bouvier J., Louis J., Bordier C., 1992. Experimental Parasitology, 75 (2) pp. 196-206.
[DOI][WoS][Pmid][serval:BIB_971245DEA6F0]
 
Membrane proteins and enzymes of Leishmania.
Schneider P., Bordier C., Etges R., 1992. Sub-cellular Biochemistry, 18 pp. 39-72.
[Pmid][serval:BIB_DC2588EA1109]
1990
 
Peptide substrate specificity of the membrane-bound metalloprotease of Leishmania.
Bouvier J., Schneider P., Etges R., Bordier C., 1990. Biochemistry, 29 (43) pp. 10113-10119.
[DOI][WoS][Pmid][serval:BIB_0AF4AA316A5A]
Structure of the glycosyl-phosphatidylinositol membrane anchor of the Leishmania major promastigote surface protease.
Schneider P., Ferguson M.A., McConville M.J., Mehlert A., Homans S.W., Bordier C., 1990. Journal of Biological Chemistry, 265 (28) pp. 16955-16964.
[URN][WoS][Pmid][serval:BIB_F39B7BB34135]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University